Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Viral Hepat ; 9(6): 429-37, 2002 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-12431205

RESUMEN

This study aimed to examine anti hepatitis C virus (HCV) antibody titres, their changes and differences in acute, chronic and past HCV infection and to examine them after IFN-alpha-therapy. Ninety five patients were studied in a cross-sectional investigation and 18 of them were followed long-term. Titres of IgM and IgG antibodies against core, NS3, NS4 (A + B), NS5A proteins were determined by the third generation enzyme immunoassays. Patients with acute hepatitis C developed IgG antibodies against core protein in titres 1/5-1/800 and against individual NS proteins at the same titres. During the first to second month of acute hepatitis C IgG antibody titres to HCV proteins were very low, but they had risen considerably by the fourth to sixth month. Anti-HCV IgM antibodies were found in half the acute hepatitis serum samples, titres were 1/5-1/40. Sixty individuals with chronic hepatitis C showed IgG antibodies against core in titres 1/800-1/40,000 and against individual NS proteins in titres 1/5-1/20,000. Eight patients with chronic hepatitis C had invariable anti-HCV IgG antibodies over 2-3 years. About 81.7% of chronically infected patients had anti-HCV IgM antibodies in titres 1/5-1/160. Patients with resolution of HCV infection showed only anti-core IgG antibodies (titres 1/5-1/200) or no virus-specific antibodies. Individuals with different response to IFN-alpha-therapy showed two distinct patterns of anti-HCV antibody titres. Acute and chronic HCV infection may be distinguished by anti-core titres.


Asunto(s)
Hepacivirus/inmunología , Anticuerpos contra la Hepatitis C/sangre , Hepatitis C/inmunología , Hepatitis C/fisiopatología , Enfermedad Aguda , Adolescente , Adulto , Antivirales/uso terapéutico , Niño , Femenino , Hepatitis C/virología , Antígenos de la Hepatitis C/inmunología , Hepatitis C Crónica/inmunología , Hepatitis C Crónica/virología , Humanos , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Interferón-alfa/uso terapéutico , Masculino , Persona de Mediana Edad
2.
Biochem Biophys Res Commun ; 179(1): 46-51, 1991 Aug 30.
Artículo en Inglés | MEDLINE | ID: mdl-1715696

RESUMEN

The effects of 10-150 nM 2,3,7,8-TCDD on the HIV infection in the various lymphoid cell cultures have been studied. The level of reproduction of HIV was examined by determination of virus antigen as well as by measurement of reverse trascriptase activity. 2,3,7,8-TCDD does not exert any toxic influence in this concentration on the MT-4 cells and causes the induction of cytochrome P-450-containing monooxygenase. Furthermore, in MT-4 cell culture infected by HIV-1 virus an increase of virus production after a treatment of cells with 2,3,7,8-TCDD has been revealed.


Asunto(s)
VIH-1/fisiología , Dibenzodioxinas Policloradas/farmacología , Antígenos Virales/análisis , Línea Celular , Relación Dosis-Respuesta a Droga , Ensayo de Inmunoadsorción Enzimática , VIH-1/efectos de los fármacos , VIH-1/enzimología , Humanos , Cinética , Linfocitos , ADN Polimerasa Dirigida por ARN/metabolismo , Proteínas Virales/análisis , Proteínas Virales/biosíntesis , Replicación Viral/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA